SCHEMBL1709535

SCHEMBL1709535

COc1ccc(SC(C(=O)Nc2ccc(Cl)cn2)c2ccc(Cl)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.49
NPC1 O15118 5/20 0.49
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 5/20 0.48
ADAM17 P78536 1/20 0.48
TSHR P16473 1/20 0.47
MAPT P10636 3/20 0.47
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
LMNA P02545 3/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
RXFP1 Q9HBX9 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
MAPK1 P28482 1/20 0.46
NPSR1 Q6W5P4 2/20 0.45
HTT P42858 2/20 0.45
PTK2 Q05397 1/20 0.45
NFKB1 P19838 1/20 0.45
CASP3 P42574 1/20 0.45
NFKB2 Q00653 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL934543 0.99 RAB9A (0.48) RAB9ANPC1KDM4EALDH1A1ADAM17
SCHEMBL12945248 0.93 RAB9A (0.47) RAB9ANPC1KDM4EALDH1A1ADAM17
SCHEMBL1709527 0.92 NPC1 (0.52) RAB9ANPC1KDM4EALDH1A1ADAM17
SCHEMBL1709594 0.91 L3MBTL1 (0.53) RAB9AALDH1A1TSHRMAPTMEN1
Hydrochloric Acid SCHEMBL934425 0.91 NPC1 (0.51) RAB9ANPC1KDM4EALDH1A1ADAM17
Hydrochloric Acid SCHEMBL933932 0.90 L3MBTL1 (0.51) RAB9AALDH1A1TSHRMAPTMEN1
SCHEMBL933295 0.87 SMN1; SMN2 (0.57) RAB9ANPC1ALDH1A1TSHRMEN1
Hydrochloric Acid SCHEMBL1286268 0.86 SMN1; SMN2 (0.56) RAB9ANPC1ALDH1A1TSHRMEN1
SCHEMBL1709614 0.85 FFAR2 (0.56) RAB9ANPC1ALDH1A1TSHRMEN1
SCHEMBL935450 0.85 FFAR2 (0.56) RAB9ANPC1ALDH1A1TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088800-A1 2-(SUBSTITUTED) (ARYLMETHYL, ARYLOXY and ARYLTHIO))-N-(SUBSTITUTED PYRIDIN-2-YL)-2-(SUBSTITUTED ARYL) COMPOUNDS AS SUBTYPE-SELECTIVE MODULATORS OF SPHINGOSINE-1-PHOSPHATE-3 (S1P3) RECEPTORS ALLERGAN, INC. (US) 2012-04-12 US disclosed
WO-2011008475-A1 OPTIONALLY SUBSTITUTED 2-(ARYLMETHYL, ARYLOXY OR ARYLTHIO) -N- PYRIDIN-2 -YL-ARYL ACETAMIDE OR 2, 2-BIS (ARYL) -N-PYRIDIN-2-YL ACETAMIDE COMPOUNDS AS MEDICAMENTS FOR THE TREATMENT OF EYE DISEASES ALLERGAN, INC. (US) 2011-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088800-A1 2-(SUBSTITUTED) (ARYLMETHYL, ARYLOXY and ARYLTHIO))-N-(SUBSTITUTED PYRIDIN-2-YL)-2-(SUBSTITUTED ARYL) COMPOUNDS AS SUBTYPE-SELECTIVE MODULATORS OF SPHINGOSINE-1-PHOSPHATE-3 (S1P3) RECEPTORS S1PR3, S1PR5, S1PR1 RAB9A 2924/4885NPC1 1507/4885KDM4E 2720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.